Your browser doesn't support javascript.
loading
High-throughput extraction on a dynamic solid phase for low-abundance biomarker isolation from biological samples.
Alexandre, Lucile; Araya-Farias, Monica; Nguyen, Manh-Louis; Naoumi, Nikoletta; Gropplero, Giacomo; Gizeli, Electra; Malaquin, Laurent; Descroix, Stéphanie.
Afiliação
  • Alexandre L; Laboratoire Physico-Chimie Curie, CNRS UMR 168, Institut Curie, PSL Research University, Paris, France.
  • Araya-Farias M; Institut Pierre-Gilles de Gennes (IPGG), Sorbonne University, Paris, France.
  • Nguyen ML; Laboratoire Physico-Chimie Curie, CNRS UMR 168, Institut Curie, PSL Research University, Paris, France.
  • Naoumi N; Institut Pierre-Gilles de Gennes (IPGG), Sorbonne University, Paris, France.
  • Gropplero G; Present Address: Frédéric Joliot Institute for Life Sciences, Pharmacology and Immunoanalysis Unit, Immunoanalysis Studies and Research Laboratory, Alternative Energies and Atomic Energy Commission (CEA), Gif-sur-Yvette, France.
  • Gizeli E; Laboratoire Physico-Chimie Curie, CNRS UMR 168, Institut Curie, PSL Research University, Paris, France.
  • Malaquin L; Institut Pierre-Gilles de Gennes (IPGG), Sorbonne University, Paris, France.
  • Descroix S; Department of Biology, University of Crete, Heraklion, Greece.
Microsyst Nanoeng ; 9: 109, 2023.
Article em En | MEDLINE | ID: mdl-37680311
ABSTRACT
Liquid biopsy, in particular circulating tumor DNA (ctDNA) analysis, has paved the way for a new noninvasive approach to cancer diagnosis, treatment selection and follow-up. As a crucial step in the analysis, the extraction of the genetic material from a complex matrix needs to meet specific requirements such as high specificity and low loss of target. Here, we developed a new generation of microfluidic fluidized beds (FBs) that enable the efficient extraction and preconcentration of specific ctDNA sequences from human serum with flow rates up to 15 µL/min. We first demonstrated that implementation of a vibration system inducing flow rate fluctuations combined with a mixture of different bead sizes significantly enhanced bead homogeneity, thereby increasing capture efficiency. Taking advantage of this new generation of high-throughput magnetic FBs, we then developed a new method to selectively capture a double-stranded (dsDNA) BRAF mutated DNA sequence in complex matrices such as patient serum. Finally, as proof of concept, ligation chain reaction (LCR) assays were performed to specifically amplify a mutated BRAF sequence, allowing the detection of concentrations as low as 6 × 104 copies/µL of the mutated DNA sequence in serum.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França